<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01022216</url>
  </required_header>
  <id_info>
    <org_study_id>XSMP-013</org_study_id>
    <nct_id>NCT01022216</nct_id>
  </id_info>
  <brief_title>Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers</brief_title>
  <official_title>A Randomized, Controlled Trial of the Procellera™ Wound Dressing Used With Negative Pressure Wound Therapy (NPWT) in the Healing of Diabetic and Pressure Ulcers of the Foot</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vomaris Innovations</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vomaris Innovations</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a bioelectric wound dressing, used in
      conjunction with Negative Pressure Wound Therapy (NPWT), is effective in the treatment of
      diabetic and pressure ulcers of the foot.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound healing over time</measure>
    <time_frame>3 months after enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain reduction</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Wound Healing</condition>
  <arm_group>
    <arm_group_label>V.A.C.® Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vacuum Assisted Closure device that utilizes controlled negative pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Procellera™ Wound Dressing with V.A.C.® Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Procellera wound dressing used as a primary contact layer on the wound bed, used in conjunction with NPWT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Procellera™ Wound Dressing with V.A.C.® Therapy</intervention_name>
    <description>Dressing indicated for partial and full-thickness wounds. Weekly dressing changes, more frequently if needed. Used as a primary contact layer in conjunction with NPWT.</description>
    <arm_group_label>Procellera™ Wound Dressing with V.A.C.® Therapy</arm_group_label>
    <other_name>PROCELLERA™, PROSIT™, Bioelectric</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>V.A.C.® Therapy</intervention_name>
    <description>Vacuum Assisted Closure device that uses controlled negative pressure, with dressing changes 1x/week.</description>
    <arm_group_label>V.A.C.® Therapy</arm_group_label>
    <other_name>Negative Pressure Wound Therapy, Vacuum Assisted Closure, V.A.C.® Therapy,</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Wound size greater than 1x1 cm

          -  Wounds must be ≥5 cm away from all other wounds

          -  Wound size must not be diminished in size greater than 10% between enrollment in study
             and the prescreening

          -  Participant must be candidate for negative pressure wound therapy

          -  Participant agrees to participate in follow-up evaluations

          -  Participant must be able to read and understand informed consent, and sign the
             informed consent

        Exclusion Criteria:

          -  Concurrent participation in another clinical trial that involves an investigational
             drug or device that would interfere with this study

          -  Participant is to receive another topical agent (antimicrobials, enzymes, etc.) other
             than the study dressing (granufoam)

          -  Participant is to receive Silver granufoam for their wound

          -  Participant with sensitivity or adverse reactions to silver or zinc

          -  Pregnancy or nursing an infant or child

          -  Immunosuppression

          -  Active or systemic infection

          -  Participant undergoing active cancer chemotherapy

          -  Chronic steroid use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald M Guberman, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wyckoff Heights Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wyckoff Heights Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11237</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2009</study_first_submitted>
  <study_first_submitted_qc>November 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2009</study_first_posted>
  <last_update_submitted>February 20, 2012</last_update_submitted>
  <last_update_submitted_qc>February 20, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 22, 2012</last_update_posted>
  <responsible_party>
    <name_title>Ronald Guberman, DPM, Director, Podiatric Medical Education</name_title>
    <organization>Wyckoff Heights Medical Center</organization>
  </responsible_party>
  <keyword>Wound</keyword>
  <keyword>Skin lesion</keyword>
  <keyword>Antimicrobial</keyword>
  <keyword>Bioelectric</keyword>
  <keyword>Diabetic foot</keyword>
  <keyword>Pressure Ulcer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Pressure Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

